Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

ACRVACRV
14 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in ACRIVON THERAPEUTICS INC

GEODE CAPITAL MANAGEMENT, LLC holds 265,241 shares of ACRV (ACRIVON THERAPEUTICS INC), worth $472,273 as of 2026-Q2. The position was increased (+12.2% shares).

Current Value

$472,273

Current Shares

265,241

Total Value Change

-$1.8M

Total Shares Change

+89,837

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
265,241
+12.2%
$472,2730.0%$1.78
18
2026-Q1
Increased
236,391
+19.3%
$328,6890.0%$1.67
19
2025-Q4
Increased
198,223
+3.2%
$477,8910.0%$2.44
17
2025-Q3
Increased
192,033
+16.8%
$347,7170.0%$1.82
19
2025-Q2
Decreased
164,362
-46.3%
$195,6740.0%$1.20
0
2025-Q1
Increased
306,111
+1.6%
$621,5780.0%$2.24
17
2024-Q4
Decreased
301,389
-0.2%
$1.8M0.0%$5.41
0
2024-Q3
Decreased
302,103
-2.0%
$2.1M0.0%$7.16
0
2024-Q2
Increased
308,393
+27.0%
$1.8M0.0%$5.80
32
2024-Q1
Increased
242,846
+28.4%
$1.7M0.0%$7.15
32
2023-Q4
Decreased
189,200
-0.2%
$930,9820.0%$4.92
0
2023-Q3
Increased
189,559
+6.2%
$1.8M0.0%$9.56
27
2023-Q2
Increased
178,453
+1.7%
$2.3M0.0%$13.32
26
2023-Q1
New
175,404
-
$2.2M0.0%$13.79
36

Other major holders of ACRV: RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used